Global Burden of Disease Study 2021 estimates: implications for health policy and research
Menée à partir de données 1990-2021 dans 204 pays et territoires, cette étude internationale estime, pour l'année 2021, l'incidence et la prévalence de 371 maladies dont le cancer, ainsi que les années vécues avec un handicap, les années de vie ajustées sur l'incapacité et l'espérance de vie en bonne santé
Over the past three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has produced several iterations of global estimates for various disease metrics. 1 The latest iteration, GBD 2021, published in The Lancet as a series of Articles, includes estimates of the global disease burden including incidence, prevalence, and disability-adjusted life-years (DALYs) for 371 diseases and injuries, at both the country level and subnational locations between 1990 and 2021